Source: candidchronicle.com
A United States cannabis pharmaceutical company has demonstrated that two cannabinoids, cannabichromene (CBC) and cannabigerol (CBG), exhibit anti-tumor properties when tested on human Gastrointestinal Cancer Cells (GCC). Following a series….
Read the rest on candidchronicle.com